In addition to the classification based on clinical information from the hospital results, we conducted a chemiluminescence assay for the expression of CA19-9 and CEA, as shown in Fig. S3, which are the clinical markers of CRC, to confirm whether these samples were related to CRC. Here, CEACAM5 is linked to colorectal carcinoma.